11 Best Strong Buy Stocks to Invest in Now

Page 4 of 10

7. Argenx SE (NASDAQ:ARGX)

Analyst Upside: 33.92%

Number of Hedge Fund Holders: 54

Argenx SE (NASDAQ:ARGX) is one of the 11 Best Strong Buy Stocks to Invest in Now. On June 16, Bank of America Securities analyst Tazeen Ahmad maintained a bullish stance on Argenx SE (NASDAQ:ARGX), giving it a Buy rating with an $804 price target. The analyst based the optimistic rating on the promising growth prospects of the company’s Vyvgart, especially in the treatment of CIDP and gMG.

The expert neurologist consulted in the report stated that Vyvgart has a suitable efficacy and a favorable safety profile, which is either comparable to or superior to that of the present treatments, such as IVIg. This factor has resulted in a notable uptake, especially in patients who have not responded well to IVIg. The analyst expects Vyvgart to capture around half the market share in CIDP over time, contributing to the positive rating for Argenx SE (NASDAQ:ARGX).

Ahmad further stated that Vyvgart’s role in the treatment of gMG is expanding, as it is becoming the leading biologic choice because of its safety and efficacy. The expected approval of the pre-filled syringe (PFS) may further support Vyvgart’s adoption, especially in large hospitals and rural areas with challenging infusion coordination.

Argenx SE (NASDAQ:ARGX) is a global immunology company that develops treatments for severe autoimmune diseases. The company operates through four segments: the United States, Japan, EMEA, and China.

Page 4 of 10